2,841 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
M Macy's Inc $35.16 $10.79B N/A
Article Searches
H&M's new diversity chief designs a more inclusive future http://www.startribune.com/h-m-s-new-diversity-chief-designs-a-more-inclusive-future/511699582/ Jun 23, 2019 - H&M is set to kick off a series of workshops and training this fall for thousands of its employees at its more than 500 North American stores aimed at addressing unconscious bias.
Lennox International Inc (LII) Chairman and CEO Todd M Bluedorn Sold $6.8 million of Shares http://www.gurufocus.com/news/898190/lennox-international-inc-lii-chairman-and-ceo-todd-m-bluedorn-sold-68-million-of-shares Jun 21, 2019 - Lennox International Inc (LII) Chairman and CEO Todd M Bluedorn Sold $6.8 million of Shares, Stocks: LII, release date:Jun 21, 2019
Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $9.8 million of Shares http://www.gurufocus.com/news/897700/vertex-pharmaceuticals-inc-vrtx-ceo--president-jeffrey-m-leiden-sold-98-million-of-shares Jun 20, 2019 - Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $9.8 million of Shares, Stocks: VRTX, release date:Jun 20, 2019
Big Drugmakers That May Tread the M&A Path After Pfizer http://www.zacks.com/stock/news/431504/big-drugmakers-that-may-tread-the-ma-path-after-pfizer?cid=CS-ZC-FT-431504 Jun 19, 2019 - There has been a flurry of M&A deal announcements this year in the drug industry. Here we discuss three big drug/biotech companies, which may make the next M&A move.
Jim Cramer shuffles his 'Humanization of Pets ETF' — 'It's paid off in 2019' https://www.cnbc.com/2019/06/17/jim-cramer-shuffles-his-pets-etf-its-paid-off-in-2019.html Jun 17, 2019 - "The humanization of pets has been a fabulous secular growth story — one that's really paid off in 2019," Cramer says.
Are You Looking for a High-Growth Dividend Stock? M&T Bank (MTB) Could Be a Great Choice http://www.zacks.com/stock/news/430450/are-you-looking-for-a-high-growth-dividend-stock-mt-bank-mtb-could-be-a-great-choice?cid=CS-ZC-FT-430450 Jun 17, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does M&T Bank (MTB) have what it takes? Let's find out.
M&A Updates: Realm Therapeutics Deal With Essa Pharma Provides An Interesting Opportunity https://seekingalpha.com/article/4270489-m-updates-realm-therapeutics-deal-essa-pharma-provides-interesting-opportunity?source=feed_all_articles Jun 16, 2019 - Realm Therapeutics is being acquired by Essa Pharma. Hunt Mining/Patagonia Gold merger provides 50% upside. One more US regional bank consolidation with a 6% spread.
Macy's Stock Could Be the Next Best Buy https://www.fool.com/investing/2019/06/15/macys-stock-could-be-the-next-best-buy.aspx?source=iedfolrf0000001 Jun 15, 2019 - The retailer is pursuing a turnaround strategy like the one that drove a remarkable comeback at Best Buy over the past seven years.
Why Dillard's (DDS) Stands Out From Department Store Peers http://www.zacks.com/stock/news/429595/why-dillards-dds-stands-out-from-department-store-peers?cid=CS-ZC-FT-429595 Jun 14, 2019 - Dillard's (DDS) gains from trendy product offerings as well as store growth and omni-channel efforts. This places it ahead of peers in an evolving retail space.
Can Legacy Payments Players Save Their Ground Through M&As? http://www.zacks.com/stock/news/429016/can-legacy-payments-players-save-their-ground-through-mas?cid=CS-ZC-FT-429016 Jun 13, 2019 - A broad set of related trends is fueling M&A activity, include continuing growth in e-commerce and a global shift from cash to electronic payments.

Pages: 123456...285

Page 1>